Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study.

Kostikas K, Vassilakopoulos TI, Tzanakis N, Konstantinidis AK, Kosmas EN, Papiris S, Steiropoulos P, Manali ED, Michaelides SA, Daskos G.

Int J Chron Obstruct Pulmon Dis. 2020 Mar 6;15:515-526. doi: 10.2147/COPD.S239044. eCollection 2020.

2.

Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies.

Vassilakopoulos TP, Asimakopoulos JV, Konstantopoulos K, Angelopoulou MK.

Ther Adv Hematol. 2020 Feb 16;11:2040620720902911. doi: 10.1177/2040620720902911. eCollection 2020. Review.

3.

Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study.

Anargyrou K, Fotiou D, Vassilakopoulos TP, Christoulas D, Makras P, Dimou M, Ntanasis-Stathopoulos I, Masouridou S, Angelopoulou MK, Papatheodorou A, Tsionos K, Panayiotidis P, Dimopoulos MA, Terpos E.

Hemasphere. 2019 Sep 24;3(6):e303. doi: 10.1097/HS9.0000000000000303. eCollection 2019 Dec.

4.

Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis.

Zinzani PL, Chen R, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Lin J, Nahar A, Balakumaran A, Moskowitz CH.

Leuk Lymphoma. 2020 Apr;61(4):950-954. doi: 10.1080/10428194.2019.1702178. Epub 2020 Jan 6. No abstract available.

PMID:
31905294
5.

Differential regulation of myofibrillar proteins in skeletal muscles of septic mice.

Moarbes V, Mayaki D, Huck L, Leblanc P, Vassilakopoulos T, Petrof BJ, Hussain SNA.

Physiol Rep. 2019 Oct;7(20):e14248. doi: 10.14814/phy2.14248.

6.

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.

Chen R, Zinzani PL, Lee HJ, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Lin J, Kim E, Nahar A, Balakumaran A, Moskowitz CH.

Blood. 2019 Oct 3;134(14):1144-1153. doi: 10.1182/blood.2019000324. Epub 2019 Aug 13.

7.

Oxidants Regulated Diaphragm Proteolysis during Mechanical Ventilation in Rats.

Moroz N, Maes K, Leduc-Gaudet JP, Goldberg P, Petrof BJ, Mayaki D, Vassilakopoulos T, Rassier D, Gayan-Ramirez G, Hussain SN.

Anesthesiology. 2019 Sep;131(3):605-618. doi: 10.1097/ALN.0000000000002837.

PMID:
31408447
8.

Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group.

Papageorgiou SG, Kontos CK, Kotsianidis I, Karousi P, Symeonidis A, Galanopoulos A, Bouchla A, Hatzimichael E, Repousis P, Zikos P, Viniou NA, Poulakidas E, Vassilakopoulos TP, Diamantopoulos P, Mparmparousi D, Bouronikou E, Papadaki H, Panayiotidis P, Pappa V.

J Geriatr Oncol. 2020 Jan;11(1):121-124. doi: 10.1016/j.jgo.2019.07.018. Epub 2019 Jul 27. No abstract available.

PMID:
31362867
9.

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies.

Vassilakopoulos TP, Chatzidimitriou C, Asimakopoulos JV, Arapaki M, Tzoras E, Angelopoulou MK, Konstantopoulos K.

Cancers (Basel). 2019 Jul 29;11(8). pii: E1071. doi: 10.3390/cancers11081071. Review.

10.

Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS).

Kotsianidis I, Papageorgiou SG, Pappa V, Galanopoulos AG, Viniou NA, Vassilakopoulos TP, Papoutselis M, Vrachiolias G, Papadopoulos V, Diamantopoulos PT, Tsokanas D, Kourakli A, Symeonidis A.

Mediterr J Hematol Infect Dis. 2019 Jul 1;11(1):e2019045. doi: 10.4084/MJHID.2019.045. eCollection 2019. No abstract available.

11.

A Unique Case of Primary Extranodal Marginal Zone Lymphoma of the Anal Canal.

Diamantopoulos P, Dryllis G, Tsourouflis G, Petevi K, Boutsikas G, Rondogianni P, Boutsis D, Korkolopoulou P, Konstantopoulos K, Angelopoulou MK, Meletis J, Kanellis G, Vassilakopoulos TP.

Acta Haematol. 2019;142(2):87-91. doi: 10.1159/000495601. Epub 2019 Jun 17.

PMID:
31207598
12.

Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in Greece.

Dimou M, Iliakis T, Pardalis V, Bitsani C, Vassilakopoulos TP, Angelopoulou M, Tsaftaridis P, Papaioannou P, Koudouna A, Kalyva S, Kyrtsonis MC, Panayiotidis P.

Leuk Lymphoma. 2019 Dec;60(12):2939-2945. doi: 10.1080/10428194.2019.1620944. Epub 2019 Jun 11.

PMID:
31184241
13.

Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical Trials.

Sachanas S, Pangalis GA, Fink AM, Bahlo J, Fischer K, Levidou G, Kyrtsonis MC, Bartzi V, Vassilakopoulos TP, Kalpadakis C, Koulieris E, Moschogiannis M, Yiakoumis X, Tsirkinidis P, Angelopoulou MK, Eichhorst B, Hallek M.

Anticancer Res. 2019 May;39(5):2591-2598. doi: 10.21873/anticanres.13382.

PMID:
31092457
14.

Regulation of breathing pattern by IL-10.

Giannakopoulou CE, Sotiriou A, Dettoraki M, Yang M, Perlikos F, Toumpanakis D, Prezerakos G, Koutsourelakis I, Kastis GA, Vassilakopoulou V, Mizi E, Papalois A, Greer JJ, Vassilakopoulos T.

Am J Physiol Regul Integr Comp Physiol. 2019 Jul 1;317(1):R190-R202. doi: 10.1152/ajpregu.00065.2019. Epub 2019 May 15.

PMID:
31091151
15.

Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome.

Diamantopoulos PT, Kontandreopoulou CN, Symeonidis A, Kotsianidis I, Pappa V, Galanopoulos A, Vassilakopoulos T, Dimou M, Solomou E, Kyrtsonis MC, Siakantaris M, Angelopoulou M, Kourakli A, Papageorgiou S, Christopoulou G, Roumelioti M, Panayiotidis P, Viniou NA; Hellenic MDS Study Group.

Ann Hematol. 2019 Jun;98(6):1383-1392. doi: 10.1007/s00277-019-03650-w. Epub 2019 Mar 15.

PMID:
30877373
16.

Detection of CALR Mutations Using High Resolution Melting Curve Analysis (HRM-A); Application on a Large Cohort of Greek ET and MF Patients.

Giannopoulos A, Rougkala N, Loupis T, Mantzourani M, Viniou NA, Variami E, Vassilakopoulos TP, Dryllis G, Kotsianidis I, Gougopoulou T, Politou M, Konstantopoulos K, Vassilopoulos G.

Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019009. doi: 10.4084/MJHID.2019.009. eCollection 2019.

17.

Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature.

Angelopoulou MK, Vassilakopoulos TP, Konstantinou E, Boutsikas G, Asimakopoulos JV, Triantafyllou EF, Petevi K, Kanellopoulos A, Moschogiannis M, Pangalis GA, Siakantaris MP, Konstantopoulos K.

Hematol Oncol. 2019 Apr;37(2):219-222. doi: 10.1002/hon.2571. Epub 2019 Feb 1. Review. No abstract available.

PMID:
30592785
18.

Prediction of dysnatremias in critically ill patients based on the law of conservation of mass. Comparison of existing formulae.

Katsiampoura A, Toumpanakis D, Konsta K, Varkaris A, Vassilakopoulos T.

PLoS One. 2018 Nov 26;13(11):e0207603. doi: 10.1371/journal.pone.0207603. eCollection 2018.

19.

Diagnostic role of cytology in serous effusions of patients with hematologic malignancies.

Savvidou K, Dimitrakopoulou A, Kafasi N, Konstantopoulos K, Vassilakopoulos T, Angelopoulou M, Siakantaris M, Korkolopoulou P, Kanavaros P, Mikou P.

Diagn Cytopathol. 2019 May;47(5):404-411. doi: 10.1002/dc.24110. Epub 2018 Nov 12.

PMID:
30417978
20.

The Economic Burden of Chronic Obstructive Pulmonary Disease in Greece.

Kourlaba G, Hillas G, Vassilakopoulos T, Maniadakis N.

Appl Health Econ Health Policy. 2019 Feb;17(1):111-121. doi: 10.1007/s40258-018-0431-5.

PMID:
30328016
21.

Non-Inherited Maternal Antigens Identify Acceptable HLA Mismatches: A New Policy for the Hellenic Cord Blood Bank.

Panagouli E, Dinou A, Mallis P, Michalopoulos E, Papassavas A, Spyropoulou-Vlachou M, Meletis J, Angelopoulou M, Konstantopoulos K, Vassilakopoulos T, Stavropoulos-Giokas C.

Bioengineering (Basel). 2018 Sep 21;5(4). pii: E77. doi: 10.3390/bioengineering5040077.

22.

The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.

Papageorgiou SG, Kontos CK, Kotsianidis I, Vasilatou D, Symeonidis A, Galanopoulos A, Bouchla A, Hatzimichael E, Repousis P, Zikos P, Viniou NA, Poulakidas E, Vassilakopoulos TP, Diamantopoulos P, Diamantopoulos MA, Mparmparousi D, Bouronikou E, Papadaki H, Panayiotidis P, Pappa V.

Hematol Oncol. 2018 Oct;36(4):693-700. doi: 10.1002/hon.2551. Epub 2018 Sep 7.

PMID:
30129144
23.

Senescence and senotherapeutics: a new field in cancer therapy.

Myrianthopoulos V, Evangelou K, Vasileiou PVS, Cooks T, Vassilakopoulos TP, Pangalis GA, Kouloukoussa M, Kittas C, Georgakilas AG, Gorgoulis VG.

Pharmacol Ther. 2019 Jan;193:31-49. doi: 10.1016/j.pharmthera.2018.08.006. Epub 2018 Aug 16. Review.

24.

Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group.

Papageorgiou SG, Kotsianidis I, Kontos CK, Symeonidis A, Galanopoulos A, Hatzimichael E, Poulakidas E, Diamantopoulos P, Vassilakopoulos TP, Zikos P, Papadaki H, Bouronikou E, Panayiotidis P, Viniou NA, Pappa V.

Leuk Res. 2018 Aug;71:55-59. doi: 10.1016/j.leukres.2018.07.004. Epub 2018 Jul 7. No abstract available.

PMID:
30007218
25.

p38 Inhibition Ameliorates Inspiratory Resistive Breathing-Induced Pulmonary Inflammation.

Toumpanakis D, Vassilakopoulou V, Mizi E, Chatzianastasiou A, Loverdos K, Vraila I, Perlikos F, Tsoukalas D, Giannakopoulou CE, Sotiriou A, Dettoraki M, Karavana V, Vassilakopoulos T.

Inflammation. 2018 Oct;41(5):1873-1887. doi: 10.1007/s10753-018-0831-6.

PMID:
29974374
26.

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.

Kalpadakis C, Pangalis GA, Sachanas S, Tsirkinidis P, Kontopidou FN, Moschogiannis M, Yiakoumis X, Koulieris E, Dimopoulou MN, Kokkoris SI, Kyrtsonis MC, Siakantaris MP, Tsourouflis G, Korkolopoulou P, Rontogianni D, Tsaftaridis P, Plata E, Papadaki HA, Panagiotidis P, Angelopoulou MK, Vassilakopoulos TP.

Blood. 2018 Aug 9;132(6):666-670. doi: 10.1182/blood-2018-02-833608. Epub 2018 Jun 18. No abstract available.

PMID:
29914978
27.

Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.

Tsirigotis P, Vassilakopoulos T, Batsis I, Bousiou Z, Gkirkas K, Sakellari I, Kaloyannidis P, Roussou P, Pangalis GA, Moschogiannis M, Vassilopoulos G, Repousis P, Megalakaki A, Michalis E, Kalpadakis C, Papadaki HA, Kotsianidis I, Hatzimichael E, Spyridonidis A, Anargyrou K, Poulakidas E, Giannoullia P, Apostolidis I, Stamouli M, Konstantopoulos K, Pappa V, Panayiotidis P, Harhalakis N, Anagnostopoulos A, Angelopoulou M.

Hematol Oncol. 2018 Oct;36(4):645-650. doi: 10.1002/hon.2521. Epub 2018 Jun 8.

PMID:
29882363
28.

The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.

Papageorgiou SG, Vasilatou D, Kontos CK, Kotsianidis I, Symeonidis A, Galanopoulos AG, Hatzimichael E, Megalakaki A, Poulakidas E, Diamantopoulos P, Vassilakopoulos TP, Zikos P, Papadaki H, Mparmparousi D, Bouronikou E, Panayiotidis P, Viniou NA, Pappa V.

Am J Hematol. 2018 Jul;93(7):895-901. doi: 10.1002/ajh.25111. Epub 2018 May 16.

29.

Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: Highlights from basic research to therapy.

Huertas A, Guignabert C, Barberà JA, Bärtsch P, Bhattacharya J, Bhattacharya S, Bonsignore MR, Dewachter L, Dinh-Xuan AT, Dorfmüller P, Gladwin MT, Humbert M, Kotsimbos T, Vassilakopoulos T, Sanchez O, Savale L, Testa U, Wilkins MR.

Eur Respir J. 2018 Apr 4;51(4). pii: 1700745. doi: 10.1183/13993003.00745-2017. Print 2018 Apr. Review.

30.

Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?

Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Vassilakopoulos TP.

Best Pract Res Clin Haematol. 2018 Mar;31(1):65-72. doi: 10.1016/j.beha.2017.10.011. Epub 2017 Nov 7. Review.

PMID:
29452668
31.

Immune cell response to strenuous resistive breathing: comparison with whole body exercise and the effects of antioxidants.

Asimakos A, Toumpanakis D, Karatza MH, Vasileiou S, Katsaounou P, Mastora Z, Vassilakopoulos T.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 7;13:529-545. doi: 10.2147/COPD.S154533. eCollection 2018.

32.

The role of Src & ERK1/2 kinases in inspiratory resistive breathing induced acute lung injury and inflammation.

Toumpanakis D, Vassilakopoulou V, Sigala I, Zacharatos P, Vraila I, Karavana V, Theocharis S, Vassilakopoulos T.

Respir Res. 2017 Dec 13;18(1):209. doi: 10.1186/s12931-017-0694-7.

33.

Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation.

Boutsikas G, Terpos E, Papatheodorou A, Tsirkinidis P, Tsirigotis P, Meletiou A, Lalou E, Telonis V, Zannou A, Kanellopoulos A, Galani Z, Stefanou A, Tsaftaridis P, Viniou NA, Panayiotidis P, Kyrtsonis MC, Meletis J, Vassilakopoulos TP, Angelopoulou MK.

Eur J Haematol. 2018 Feb;100(2):131-139. doi: 10.1111/ejh.12990. Epub 2017 Dec 4.

PMID:
29105864
34.

The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials.

Angelopoulou MK, Mosa E, Pangalis GA, Rondogianni P, Chatziioannou S, Prassopoulos V, Moschogianni M, Tsirkinidis P, Asimakopoulos JV, Konstantinou I, Tsourouflis G, Sachanas S, Yiakoumis X, Boutsikas G, Arapaki M, Gainaru G, Kyrtsonis MC, Siakantaris MP, Datseris I, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP.

Anticancer Res. 2017 Oct;37(10):5727-5736.

PMID:
28982893
35.

Protein Z (PZ) and plasminogen activator inhibitor-1 (PAI-1) plasma levels in patients with previously untreated Hodgkin lymphoma (HL).

Boutsikas G, Terpos E, Markopoulos A, Papatheodorou A, Stefanou A, Georgiou G, Galani Z, Komninaka V, Telonis V, Anagnostopoulos I, Dimitrakopoulou L, Anargyrou K, Tsionos K, Christoulas D, Gonianaki M, Giannikos T, Kokoris S, Konstantopoulos K, Meletis J, Angelopoulou MK, Travlou A, Vassilakopoulos TP.

J BUON. 2017 Jul-Aug;22(4):1022-1031.

36.

Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.

Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N, Marin J, Miculinic N, Polese G, Samaržija M, Skrgat S, Vassilakopoulos T, Vukić-Dugac A, Zakynthinos S, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017. Review. Erratum in: Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:247.

37.

Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction.

Toumpanakis D, Loverdos K, Tzouda V, Vassilakopoulou V, Litsiou E, Magkou C, Karavana V, Pieper M, Vassilakopoulos T.

Int J Chron Obstruct Pulmon Dis. 2017 Jul 28;12:2207-2220. doi: 10.2147/COPD.S137587. eCollection 2017.

38.

Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.

Zagouri F, Kastritis E, Zomas A, Terpos E, Katodritou E, Symeonidis A, Delimpasi S, Pouli A, Vassilakopoulos TP, Michalis E, Giannouli S, Kartasis Z, Christoforidou A, Kokoviadou K, Hatzimichael E, Gika D, Megalakaki C, Papaioannou M, Kyrtsonis MC, Konstantopoulos K, Dimopoulos MA; Greek Myeloma Study Group.

Eur J Haematol. 2017 Nov;99(5):409-414. doi: 10.1111/ejh.12923. Epub 2017 Sep 26.

PMID:
28675766
39.

Bone metabolism markers and angiogenic cytokines as regulators of human hematopoietic stem cell mobilization.

Tsirkinidis P, Terpos E, Boutsikas G, Papatheodorou A, Anargyrou K, Lalou E, Dimitrakopoulou A, Kalpadakis C, Konstantopoulos K, Siakantaris M, Panayiotidis P, Pangalis G, Kyrtsonis MC, Vassilakopoulos T, Angelopoulou MK.

J Bone Miner Metab. 2018 Jul;36(4):399-409. doi: 10.1007/s00774-017-0853-4. Epub 2017 Jun 28.

PMID:
28660376
40.

Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece.

Gourzoulidis G, Kourlaba G, Kakisis J, Matsagkas M, Giannakoulas G, Gourgoulianis KI, Vassilakopoulos T, Maniadakis N.

Clin Drug Investig. 2017 Sep;37(9):833-844. doi: 10.1007/s40261-017-0540-1.

PMID:
28608312
41.

The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece.

Souliotis K, Kousoulakou H, Hillas G, Tzanakis N, Toumbis M, Vassilakopoulos T.

Int J Chron Obstruct Pulmon Dis. 2017 May 10;12:1395-1400. doi: 10.2147/COPD.S132825. eCollection 2017.

42.

Tumor Protein 53 Gene Mutations Without 17p13 Deletion Have No Significant Clinical Implications in Chronic Lymphocytic Leukemia. Detection of a New Mutation.

Diamantopoulos PT, Samara S, Kollia P, Giannakopoulou N, Sofotasiou M, Kalala F, Kodandreopoulou E, Zervakis P, Vassilakopoulos T, Siakantaris M, Mantzourani M, Angelopoulou M, Kyrtshonis MC, Korkolopoulou P, Patsouris E, Viniou NA.

Anticancer Res. 2017 May;37(5):2387-2391.

PMID:
28476805
43.

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.

Chen R, Zinzani PL, Fanale MA, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Zhang Y, Ricart AD, Balakumaran A, Moskowitz CH; KEYNOTE-087.

J Clin Oncol. 2017 Jul 1;35(19):2125-2132. doi: 10.1200/JCO.2016.72.1316. Epub 2017 Apr 25.

44.

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach.

Souliotis K, Kousoulakou H, Hillas G, Bakakos P, Toumbis M, Loukides S, Vassilakopoulos T.

Front Public Health. 2017 Apr 5;5:67. doi: 10.3389/fpubh.2017.00067. eCollection 2017.

45.

Treatment of splenic marginal zone lymphoma.

Kalpadakis C, Pangalis GA, Angelopoulou MK, Vassilakopoulos TP.

Best Pract Res Clin Haematol. 2017 Mar - Jun;30(1-2):139-148. doi: 10.1016/j.beha.2016.07.004. Epub 2016 Nov 4. Review.

PMID:
28288709
46.

Diaphragmatic ultrasound as a monitoring tool in the intensive care unit.

Sigala I, Vassilakopoulos T.

Ann Transl Med. 2017 Feb;5(4):79. doi: 10.21037/atm.2017.01.68. No abstract available.

47.

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.

Angelopoulou MK, Vassilakopoulos TP, Batsis I, Sakellari I, Gkirkas K, Pappa V, Giannoulia P, Apostolidis I, Apostolopoulos C, Roussou P, Panayiotidis P, Dimou M, Kyrtsonis MC, Palassopoulou M, Vassilopoulos G, Moschogiannis M, Kalpadakis C, Margaritis D, Spyridonidis A, Michalis E, Anargyrou K, Repousis P, Hatzimichael E, Bousiou Z, Poulakidas E, Grentzelias D, Harhalakis N, Pangalis GA, Anagnostopoulos A, Tsirigotis P.

Hematol Oncol. 2018 Feb;36(1):174-181. doi: 10.1002/hon.2383. Epub 2017 Feb 20.

48.

Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes.

Diamantopoulos P, Zervakis K, Zervakis P, Sofotasiou M, Vassilakopoulos T, Kotsianidis I, Symeonidis A, Pappa V, Galanopoulos A, Solomou E, Kodandreopoulou E, Papadopoulou V, Korkolopoulou P, Mantzourani M, Kyriakakis G, Viniou NA.

Blood Cancer J. 2017 Feb 17;7(2):e533. doi: 10.1038/bcj.2016.127.

49.

A Stimulating Approach to Ventilator-induced Diaphragmatic Dysfunction.

Vassilakopoulos T, Petrof BJ.

Am J Respir Crit Care Med. 2017 Feb 1;195(3):281-282. doi: 10.1164/rccm.201608-1619ED. No abstract available.

PMID:
28145756
50.

Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?

Vassilakopoulos TP, Asimakopoulos JV, Plata E, Kelepesis G, Petevi K, Koutsi C, Papageorgiou L, Tsaftaridis P, Angelopoulou MK, Konstantopoulos K, Meletis J.

Leuk Lymphoma. 2017 Jul;58(7):1743-1746. doi: 10.1080/10428194.2016.1253838. Epub 2016 Dec 6. No abstract available.

PMID:
27919176

Supplemental Content

Loading ...
Support Center